AxoGen, Inc. (AXGN) DCF Valuation

AxoGen, Inc. (AXGN) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

AxoGen, Inc. (AXGN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true value of AxoGen, Inc. (AXGN) with our professional-grade DCF Calculator! Adjust key assumptions, explore various scenarios, and evaluate how changes affect AxoGen, Inc. (AXGN) valuation – all within a single Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 106.7 112.3 127.4 138.6 159.0 175.8 194.3 214.8 237.5 262.6
Revenue Growth, % 0 5.24 13.41 8.81 14.74 10.55 10.55 10.55 10.55 10.55
EBITDA -26.2 -19.3 -20.9 -23.5 -13.3 -29.3 -32.4 -35.9 -39.6 -43.8
EBITDA, % -24.57 -17.16 -16.4 -16.94 -8.38 -16.69 -16.69 -16.69 -16.69 -16.69
Depreciation 2.9 3.5 4.7 4.9 5.6 5.8 6.4 7.1 7.8 8.7
Depreciation, % 2.7 3.08 3.72 3.5 3.49 3.3 3.3 3.3 3.3 3.3
EBIT -29.1 -22.7 -25.6 -28.3 -18.9 -35.1 -38.8 -42.9 -47.5 -52.5
EBIT, % -27.26 -20.24 -20.12 -20.44 -11.87 -19.99 -19.99 -19.99 -19.99 -19.99
Total Cash 96.5 104.0 84.1 48.8 31.0 106.8 118.1 130.5 144.3 159.5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 16.9 17.6 18.2 22.2 25.1
Account Receivables, % 15.88 15.69 14.26 16.01 15.81
Inventories 13.9 12.5 16.7 18.9 23.0 23.0 25.4 28.1 31.1 34.3
Inventories, % 12.99 11.16 13.11 13.64 14.48 13.07 13.07 13.07 13.07 13.07
Accounts Payable 8.3 4.6 5.9 9.0 11.8 10.7 11.8 13.0 14.4 15.9
Accounts Payable, % 7.74 4.09 4.65 6.47 7.4 6.07 6.07 6.07 6.07 6.07
Capital Expenditure -121.6 -22.6 -28.4 -21.3 -14.9 -58.8 -65.0 -71.8 -79.4 -87.8
Capital Expenditure, % -113.99 -20.12 -22.3 -15.34 -9.38 -33.43 -33.43 -33.43 -33.43 -33.43
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -29.1 -23.7 -26.7 -26.7 -18.9 -34.7 -38.4 -42.5 -46.9 -51.9
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -170.4 -45.8 -53.7 -46.3 -32.5 -90.9 -101.1 -111.8 -123.6 -136.6
WACC, % 9.31 9.31 9.31 9.29 9.31 9.3 9.3 9.3 9.3 9.3
PV UFCF
SUM PV UFCF -427.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -139
Terminal Value -1,908
Present Terminal Value -1,223
Enterprise Value -1,651
Net Debt 38
Equity Value -1,689
Diluted Shares Outstanding, MM 43
Equity Value Per Share -39.39

What You Will Get

  • Real AxoGen Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on AxoGen’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.

Key Features

  • Pre-Loaded Data: AxoGen, Inc.'s historical financial statements and pre-filled forecasts.
  • Fully Adjustable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
  • Instant Results: View AxoGen, Inc.'s intrinsic value recalculating in real time.
  • Clear Visual Outputs: Dashboard charts present valuation results and essential metrics.
  • Built for Accuracy: A professional tool tailored for analysts, investors, and finance professionals.

How It Works

  • Download: Obtain the pre-prepared Excel file featuring AxoGen, Inc.'s (AXGN) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and instantly compare results.
  • Make Decisions: Utilize the valuation findings to inform your investment approach.

Why Choose This Calculator for AxoGen, Inc. (AXGN)?

  • Accurate Data: Utilize real AxoGen financials for trustworthy valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you from starting from ground zero.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the healthcare sector.
  • User-Friendly: An intuitive design and step-by-step guidance ensure accessibility for all users.

Who Should Use AxoGen, Inc. (AXGN)?

  • Medical Students: Understand nerve regeneration techniques and apply them in clinical scenarios.
  • Researchers: Utilize advanced models in your studies on nerve repair and regeneration.
  • Healthcare Investors: Evaluate your investment strategies and analyze market trends for AxoGen, Inc. (AXGN).
  • Industry Analysts: Enhance your analysis with a comprehensive, customizable valuation model specific to the biotech sector.
  • Surgeons: Discover how innovative technologies are transforming surgical practices in nerve repair.

What the Template Contains

  • Pre-Filled DCF Model: AxoGen, Inc.’s (AXGN) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate AxoGen, Inc.’s (AXGN) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.